The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis

Published:2020-05-15 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zhong Xi,Zhou Yue,Cui Wanbin,Su Xin,Guo Zhexu,Hidasa Iko,Li Qincai,Wang Zhenning,Song Yongxi

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Wildtype KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer;Amado;J. Clin. Oncol.,2008

2. Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer;Bengala;Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.,2009

3. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921;Bosset;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2005

4. Chemotherapy with preoperative radiotherapy in rectal cancer;Bosset;New Engl. J. Med.,2006

5. Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer;Craven;Br. J. Cancer,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments in Checkpoint Inhibitor Therapy for the Management of Deficient Mismatch Repair (dMMR) Rectal Cancer;Current Oncology;2023-03-26

2. Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?;Molecular Therapy - Oncolytics;2021-09

3. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer;Cancers;2021-07-20

4. High-Risk Clinicopathological and Genetic Features and Outcomes in Patients Receiving Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer;Cancers;2021-06-24